GRI Bio Inc - GRI Company Long-Term Liabilities

Symbol and logo of brand GRI Bio Corp (GRI)

This current chart of long-term liabilities for GRI Bio, Inc. (GRI) demonstrates the financial profile of a company possessing significant market influence in the field of immunology due to unique molecules for combating liver fibrosis. The metric value is 0.00. The organization is actively developing NKT-cell modulators for the therapy of pulmonary inflammation. Fundamental success is based on the creation of a patent portfolio that will ensure the future commercialization of innovative treatment methods.

GRI gribio.com Company Long-Term Liabilities (02/21/2024 - 10/28/2026)

GRI Bio Corp - analytical breakdowns and key metrics (GRI)

- price and consensus price forecast:
Price Performance Chart gribio.com|GRI - Price Target Chart
- market capitalization data:
Market Valuation GRI Bio|GRI - Enterprise Value
- book capitalization data:
Book Value per Share GRI Bio|GRI - Company Net Assets|Market Value to Book Value gribio.com|GRI - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Coefficient GRI Bio, Inc.|GRI - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio GRI Bio Corporation|GRI - Company Debts|Debt to Book Value GRI Bio|GRI - Company Long-Term Liabilities|Company Short-Term Debts GRI Bio
Fundamental company valuation:GRI - gribio.com
Manufactured products of GRI Bio, Inc.

For GRI Bio, Inc. (GRI), long-term liabilities reflect the ability to fund costly R&D projects in the absence of current revenue. This metric aggregates all credit obligations with a maturity of more than one year, measuring the debt load on capital. By analyzing the issuer's long-term liability statistics, an investor assesses the risk of default amid rising interest rates. Debt growth here logically accompanies the expansion of the immunotherapy pipeline. Indicator lows may signal a slowdown in the scaling of clinical trials.

Who GRI Bio, Inc. competes with

argenx.com - Company Long-Term Loans and Borrowings|BNTX: Company Long-Term Debt|ABVX - Company Long-Term Liabilities|ADMA: Company Long-Term Debts|Company Long-Term Debts Protagonist Corp|IMVT - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings kiniksa.com|GRFS (Grifols) - Company Long-Term Debts|Long-Term Debt Volume ADPT (Adaptive Biotech)|Celldex - Company Long-Term Debt|Aurinia Corp - Company Long-Term Liabilities|BCRX: Company Long-Term Debt|veratx.com (VERA) - Company Long-Term Liabilities|DNTH: Company Long-Term Liabilities|PHVS (Pharvaris NV) - Company Long-Term Debts|Company Long-Term Debt AbCellera Biologics (ABCL)|Company Long-Term Indebtedness Tourmaline|Precigen, Inc. - Company Long-Term Debts|Long-Term Debt pharming.com (PHAR)|NKTR (Nektar Therapeutics Inc.) - Company Long-Term Debts|Upstream Bio, Inc. - Long-Term Indebtedness|Company Long-Term Debt Zenas Biopharma, Inc. (ZBIO)|IMNM - Company Long-Term Loans and Borrowings|Gossamer Bio, Inc. - Company Long-Term Debts|Long-Term Debt Volume kalvista.com|SEPN - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings Pieris Pharma|Company Long-Term Debts Savara Corp (SVRA)|Company Long-Term Debt Rigel Corp (RIGL)|Company Long-Term Debts ANAB|astriatx.com - Long-Term Debt Volume|ENGN (enGene) - Company Long-Term Debt|rapt.com (RAPT) - Long-Term Debt|Company Long-Term Liabilities aerovatetx.com JBIO|Aclaris Therapeutics, Inc (ACRS) - Company Long-Term Loans and Borrowings|KYTX: Company Long-Term Debts|Long-Term Debt Volume TLSA|Company Long-Term Debt Cabaletta Bio CABA|Company Long-Term Indebtedness Ventyx Biosciences Inc. (VTYX)|Theratechnologies Inc - Company Long-Term Debts|AVTX - Company Long-Term Liabilities|Company Long-Term Liabilities ELDN (Eledon Pharmaceuticals)|AGEN - Long-Term Debt Volume|Company Long-Term Debts CLYM (Climb Bio)|ZURA (zurabio.com) - Long-Term Indebtedness|ATYR - Company Long-Term Debt|Company Long-Term Loans and Borrowings Adagene Corp|IMA (ImageneBio Inc) - Company Long-Term Debts|Long-Term Debt Volume STTK (shattucklabs.com)|Equillium (EQ) - Company Long-Term Debt|Long-Term Liabilities Connect Biopharma Holdings CNTB|Company Long-Term Debts Immunic Inc (IMUX)|ATRA - Company Long-Term Loans and Borrowings|IFRX: Company Long-Term Debts|XFOR (x4pharma.com) - Company Long-Term Debts|ACET - Company Long-Term Debt|Company Long-Term Loans and Borrowings CELU|Company Long-Term Debt INMB (INmune Bio Corp)|Company Long-Term Liabilities Barinthus Biotherapeutics Corp (BRNS)|Company Long-Term Debts KZR (Kezar Life Sciences)|SABS - Company Long-Term Debts|Company Long-Term Liabilities Akari Therapeutics Plc (AKTX)|ENLV - Company Long-Term Loans and Borrowings|q32bio.com - Company Long-Term Debts|GOVX (GeoVax Corp) - Long-Term Debt Volume|Company Long-Term Debt EDSA|Company Long-Term Liabilities IBIO|Company Long-Term Debt CARM (Carisma Therapeutics)|Company Long-Term Liabilities XTL Biopharmaceuticals Ltd XTLB|Company Long-Term Liabilities BOLT (Bolt Biotherapeutics, Inc.)|HCW Biologics, Inc. - Company Long-Term Debts|Aptevo (APVO) - Company Long-Term Debt|AIM - Company Long-Term Indebtedness|Company Long-Term Debts ADTX|XORTX Therapeutics Inc (XRTX) - Long-Term Debt|ReShape Lifesciences - Company Long-Term Debts|Long-Term Indebtedness REVB|Indaptus Therapeutics (INDP) - Company Long-Term Debt|Company Long-Term Loans and Borrowings scinai.com (SCNI)|Company Long-Term Debts CALI|AFMD - Long-Term Debt Volume|Company Long-Term Liabilities Allakos Therapeutics (ALLK)|HOOK - Company Long-Term Loans and Borrowings|igmbio.com (IGMS) - Company Long-Term Debts|iteostherapeutics.com (ITOS) - Company Long-Term Debt|OCEA: Company Long-Term Debts|Long-Term Debt Volume TCBP|Third Harmonic Bio, Inc - Company Long-Term Debt